NEW YORK (GenomeWeb News) – Agilent Technologies today said it will collaborate with Cell Line Genetics to develop high-throughput, genomic characterization workflows for confirming and monitoring the integrity of cell lines for translational and regenerative medicine research.

The workflows will be based on Agilent's CGH+SNP microarrays and SureFISH technologies. The arrays will be used to detect amplifications, deletions, and cell line clonality, while the FISH assays will be used to confirm aberrations "identified down to the single-cell level," said Agilent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.